dots health software glp-1 habit logging GLP-1s can support change BookFactorys GLP Did you know GLP-1 is
Description
The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
75 A comparative study conducted in China over 24 weeks evaluated the treatment of MASLD and T2DM in patients not receiving additional glucose control medications
Ozempic encourages the pancreas to release insulin when blood sugar levels are high and prevents the liver from producing and releasing excessive sugar
The medication also increases water retention in the intestinal lumen, which helps create satiety but may influence bowel habits and stool consistency
Another study found modest or variable indications of development of tolerance after repeated liraglutide administration (Vallf et al., 2016)
